KDR and thyroid gland carcinoma: The ubiquitin E3 ligase SCF (β-TRCP) can promote the ubiquitination and degradation of VEGFR2 in a casein kinase I (CKI)-dependent manner, reduce VEGFR2, and inhibit the angiogenesis and metastasis of thyroid cancer [25].